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Antigen-specific DNA vaccine immunotherapy is an
attractive approach for the treatment of cancer since it has
the potency to specifically eradicate systemic tumors with-
out damaging the normal cells. However, DNA vaccine
shows insufficient immune response for antigen present-
ing cells and has minimal clinical efficacies. Cryoablation
therapy is the therapeutic application of extreme cold for
localized destruction of living tissue. It can develop cancer
cell necrosis and release damage-associated molecular
patterns (DAMPs) in tumor microenvironment. According
to other reports, cryotherapy has immunogenic potential.
Therefore, we explored the employment of cryoablation in
combination with HPV E7 specific CRT/E7 DNA vaccine
in a preclinical mouse model. For in vivo experiment, the
mice were divided into four groups: group 1 received no
treatment after the E7-expressing TC-1 tumor challenge,
group 2 was treated with cryoablation therapy, group
3 was immunized with the CRT/E7 DNA vaccine, and
group 4 was both immunized and received cryoablation
therapy. Mice were monitored for E7-specific CD8 (+) T
cell immune responses, myeloid-derived suppressor cells
(MDSCs) and antitumor effects. In vitro assay, TC-1 cells
were incubated in deep freezing and thawed for determi-
nation of HMGB1 from the supernatant. The combination
therapy of cryoablation and CRT/E7 DNA vaccination
significantly inhibited tumor growth and increased E7-
specific CD8+ T cells in spleen compared to other treat-
ment groups. Furthermore, the immunosuppressive
MDSCs in tumor mass were significantly decreased in
combination therapy group. We found that treatment with
deep freezing and thawing led to up-regulation of HMGB1
in TC-1 tumor cells, rendering the tumor cells more
susceptible to APCs and E7-specific CD8+ T cell-mediated
killing. In conclusion, cryoablation therapy can enhance
therapeutic HPV DNA vaccine potency in generating
improved antigen-specific immune responses and antitu-
mor effects through the DAMP signal. These findings
have important implications for future clinical translation.
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